AHA Scientific Sessions 2026 Abstract · Nov 2, 2026
Discrepancy Between Cystatin C and Creatinine Estimated Glomerular Filtration Rate with Type 2 Diabetes and Progression to Cardiovascular Disease A National Cohort Study
By Cui C, Zhang L, Chen S et al.
Background: Difference between estimated glomerular filtration rates by cystatin C and creatinine (eGFRdiff) has been linked to cardiovascular disease, yet little is known about its implications on the risk of diabetes. This study aimed to investigate the associations of eGFRdiff with incident diabetes and the progression to cardiovascular disease using a nationally representative cohort. Methods: This study included 10,958 participants aged 45 years or older free of diabetes at wave 2015 from China Health and Retirement Longitudinal Study (CHARLS). We calculated eGFRdiff by the absolute difference between cystatin C- and creatinine-based eGFR levels. Cox proportional hazards regression and linear regression models were used to evaluate the associations of eGFRdiff with incident diabetes and its parameters, and the development of cardiovascular disease. Results: The mean age of the participants was 60.4±9.7 years, and 5,722 (52.2%) were females. During a median follow-up of 5.0 years, 1,056 cases (9.6%) developed diabetes. Compared to the midrange eGFRdiff group (from -15 to 15 mL/min/1.73 m ² ), those in the negative group (< -15 mL/min/1.73 m ² ) had a 17% greater risk of diabetes (HR 1.17, 95% CI 1.01-1.36) after eGFR level and other covariates were adjusted. Cross-sectionally, participants in the negative eGFRdiff group had an average 2.41 (95% CI 1.20-3.62) higher glucose (mg/dL) and a 0.06 (95% CI 0.03-0.09) higher HbA1c (%), compared to the midrange group. Diabetes significantly mediated 48.3% of the associations between eGFRdiff and cardiovascular disease. Conclusions: In conclusion, a large negative discordance between cystatin C- and creatinine-based eGFR is associated incident diabetes and the progression to cardiovascular disease. Keywords: Estimated Glomerular Filtration Rate; Cystatin C; Diabetes; Cardiovascular disease